Recombinant Human MIP-5 (CCL15)|重組人巨噬細(xì)胞炎性蛋白5
產(chǎn)品名稱: Recombinant Human MIP-5 (CCL15)|重組人巨噬細(xì)胞炎性蛋白5
產(chǎn)品型號(hào): C22-204-15
產(chǎn)品展商: PERFEMIKER
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Recombinant Human MIP-5 (CCL15)|重組人巨噬細(xì)胞炎性蛋白5 現(xiàn)貨促銷，>97% by SDS-PAGE and HPLC analyses.
Recombinant Human MIP-5 (CCL15)|重組人巨噬細(xì)胞炎性蛋白5
的詳細(xì)介紹
產(chǎn)品名稱：Recombinant Human MIP-5 (CCL15)|重組人巨噬細(xì)胞炎性蛋白5
單 位：支
Recombinant Human MIP-5 (CCL15)|重組人巨噬細(xì)胞炎性蛋白5，國(guó)產(chǎn)細(xì)胞因子,cytokine
產(chǎn)品詳細(xì)介紹：
C22-204-15 5μg/￥500 25μg/￥1000 1mg/詢價(jià)
Purity:
>97% by SDS-PAGE and HPLC analyses.
Biological Activity:
Fully biologically active when compared to standard. Determined by its ability to chemoattract human T lymphocytes using a concentration range of 1.0 -10.0 ng/ml.
Storage:
This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.
